Paul Tudor Jones's IRMD Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 31,177 shares of IRADIMED CORPORATION (IRMD) worth $3.03 M, representing 0.01% of the portfolio. First purchased in 2023-Q1, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in IRMD, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 21,817 shares. Largest reduction occurred in Q2 2025, reducing 23,467 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's IRADIMED CORPORATION (IRMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly IRADIMED CORPORATION (IRMD) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +21,817 | Add 233.09% | 31,177 | $97.28 |
| Q3 2025 | +9,360 | New Buy | 9,360 | $71.16 |
| Q2 2025 | -23,467 | Sold Out | 0 | $0.00 |
| Q1 2025 | -7,549 | Reduce 24.34% | 23,467 | $52.48 |
| Q4 2024 | +8,147 | Add 35.62% | 31,016 | $55.00 |
| Q3 2024 | +17,820 | Add 352.94% | 22,869 | $50.29 |
| Q2 2024 | +5,049 | New Buy | 5,049 | $43.94 |
| Q1 2024 | -6,963 | Sold Out | 0 | $0.00 |
| Q4 2023 | -9,390 | Reduce 57.42% | 6,963 | $47.47 |
| Q3 2023 | +634 | Add 4.03% | 16,353 | $44.37 |
| Q2 2023 | +6,817 | Add 76.58% | 15,719 | $47.74 |
| Q1 2023 | +8,902 | New Buy | 8,902 | $0.04 |
Paul Tudor Jones's IRADIMED CORPORATION Investment FAQs
Paul Tudor Jones first purchased IRADIMED CORPORATION (IRMD) in Q1 2023, acquiring 8,902 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held IRADIMED CORPORATION (IRMD) for 12 quarters since Q1 2023.
Paul Tudor Jones's largest addition to IRADIMED CORPORATION (IRMD) was in Q4 2025, adding 31,177 shares worth $3.03 M.
According to the latest 13F filing for Q4 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 31,177 shares of IRADIMED CORPORATION (IRMD), valued at approximately $3.03 M.
As of the Q4 2025 filing, IRADIMED CORPORATION (IRMD) represents approximately 0.01% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in IRADIMED CORPORATION (IRMD) was 31,177 shares, as reported at the end of Q4 2025.